Gino Santini - Net Worth and Insider Trading
Gino Santini Net Worth
The estimated net worth of Gino Santini is at least $72 Million dollars as of 2024-04-26. Gino Santini is the Sr.VP, Corp. Strategy & Policy of Eli Lilly and Co and owns about 89,010 shares of Eli Lilly and Co (LLY) stock worth over $65 Million. Gino Santini is also the Director of Horizon Therapeutics PLC and owns about 63,303 shares of Horizon Therapeutics PLC (HZNP) stock worth over $7 Million. Details can be seen in Gino Santini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gino Santini has not made any transactions after 2021-03-01 and currently still holds the listed stock(s).
Transaction Summary of Gino Santini
Gino Santini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gino Santini owns 7 companies in total, including Horizon Therapeutics PLC (HZNP) , AMAG Pharmaceuticals Inc (AMAG) , and Intercept Pharmaceuticals Inc (ICPT) among others .
Click here to see the complete history of Gino Santini’s form 4 insider trades.
Insider Ownership Summary of Gino Santini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2021-03-01 | director |
| AMAG | AMAG Pharmaceuticals Inc | 2020-06-02 | director |
| ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
| COLL | Collegium Pharmaceutical Inc | 2022-05-19 | director |
| ALNAQ | Allena Pharmaceuticals Inc | 2017-11-01 | director |
| VTAE | Vitae Pharmaceuticals Inc | 2016-10-25 | director |
| LLY | Eli Lilly and Co | 2005-12-15 | President & US Operations |
Gino Santini Latest Holdings Summary
Gino Santini currently owns a total of 2 stocks. Among these stocks, Gino Santini owns 89,010 shares of Eli Lilly and Co (LLY) as of December 15, 2005, with a value of $65 Million and a weighting of 89.76%. Gino Santini also owns 63,303 shares of Horizon Therapeutics PLC (HZNP) as of March 1, 2021, with a value of $7 Million and a weighting of 10.24%.
Latest Holdings of Gino Santini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2005-12-15 | 89,010 | 724.87 | 64,520,679 |
| HZNP | Horizon Therapeutics PLC | 2021-03-01 | 63,303 | 116.30 | 7,362,139 |
Holding Weightings of Gino Santini
Gino Santini Form 4 Trading Tracker
According to the SEC Form 4 filings, Gino Santini has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 5,000 shares on December 15, 2005, which brought Gino Santini around $280,700.
According to the SEC Form 4 filings, Gino Santini has made a total of 1 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 12,000 shares on March 1, 2021, which brought Gino Santini around $1 Million.
Insider Trading History of Gino Santini
- 1
Gino Santini Trading Performance
Gino Santini Ownership Network
Ownership Network List of Gino Santini
Ownership Network Relation of Gino Santini
Gino Santini Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Gino Santini is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Gino Santini made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Gino Santini Mailing Address
Above is the net worth, insider trading, and ownership report for Gino Santini. You might contact Gino Santini via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
